EDGAR Filing Documents for 0001387131-10-000053

Form 8-K - Current report:

SEC Accession No. 0001387131-10-000053

Filing Date

2010-01-15

Accepted

2010-01-15 17:12:10

Documents

Period of Report

2010-01-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	adamis-8k_0114.htm	8-K	47954
2	SECURITIES PURCHASE AGREEMENT	ex-10_1.htm	EX-10.1	147513
3	10% SENIOR SECURED CONVERTIBLE NOTE	ex-10_2.htm	EX-10.2	140196
4	SECURITY AGREEMENT	ex-10_3.htm	EX-10.3	217635
5	FORM OF LOCK-UP AGREEMENT	ex-10_4.htm	EX-10.4	27117
6	SUBSIDIARY GUARANTEE AGREEMENT	ex-10_5.htm	EX-10.5	100340
	Complete submission text file	0001387131-10-000053.txt		682570

Mailing Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951

Business Address 2085?B? QUAKER POINT DRIVE QUAKERTOWN PA 18951 215-529-6084

Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)